This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB.The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 43: 1089-1134, No. 9, 1 Nov 2006
Rights and permissions
About this article
Cite this article
Updated guidelines for the management of patients with Lyme disease, babesiosis and human granulocytic anaplasmosis have been released. Pharmacoecon. Outcomes News 514, 2 (2006). https://doi.org/10.2165/00151234-200605140-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605140-00002